ConductScience.org, home

Paper42332001

An approach to assess the impact of measures mitigating burden associated with COVID-19 in Central Asia (Kazakhstan, Kyrgyzstan, Mongolia).

Kozhekenova N and 15 others. Sci Rep, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. An approach to assess the impact of measures mitigating burden associated with COVID-19 in Central Asia (Kazakhstan, Kyrgyzstan, Mongolia). Papers, record 42332001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42332001

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An approach to assess the impact of measures mitigating burden associated with COVID-19 in Central Asia (Kazakhstan, Kyrgyzstan, Mongolia).
PubMed
Journal
Sci Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-05
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Humans
Male
Kyrgyzstan
Mongolia
Female
Retrospective Studies
SARS-CoV-2
Kazakhstan
Middle Aged
Adult
Aged
Adolescent
Child, Preschool
Child
Young Adult
Asia, Central
Infant
Pandemics

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BR24992814Committee of Science of the Ministry of Science and Higher Education of the Republic of KazakhstanPubMed

Source PubMed

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139233048COVID-19 increased existing gender mortality gaps in high-income more than middle-income countries.Int J Infect Dis2024https://conductscience.org/library/papers/39233048PubMed
234218863COVID-19 Gender Disparities and Mitigation Recommendations: A Narrative Review.Mayo Clin Proc2021https://conductscience.org/library/papers/34218863PubMed
337433726Excess deaths directly and indirectly attributable to COVID-19 using routinely reported mortality data, Bishkek, Kyrgyzstan, 2020: a cross-sectional study.BMJ Open2023https://conductscience.org/library/papers/37433726PubMed
435422585Sex-disaggregated data matters: tracking the impact of COVID-19 on the health of women and men.Econ Polit (Bologna)2022https://conductscience.org/library/papers/35422585PubMed
534327444Mass testing for COVID-19 in Ulaanbaatar, Mongolia: "One door-one test" approach.Lancet Reg Health West Pac2021https://conductscience.org/library/papers/34327444PubMed
635206453Seropositivity of SARS-CoV-2 in the Population of Kazakhstan: A Nationwide Laboratory-Based Surveillance.Int J Environ Res Public Health2022https://conductscience.org/library/papers/35206453PubMed
735208577Towards an Accurate Estimation of COVID-19 Cases in Kazakhstan: Back-Casting and Capture-Recapture Approaches.Medicina (Kaunas)2022https://conductscience.org/library/papers/35208577PubMed
838902661Excess mortality during the COVID-19 pandemic in low-and lower-middle-income countries: a systematic review and meta-analysis.BMC Public Health2024https://conductscience.org/library/papers/38902661PubMed
932793620COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis.Front Med (Lausanne)2020https://conductscience.org/library/papers/32793620PubMed
1037351091Effectiveness of four vaccines in preventing SARS-CoV-2 infection in Almaty, Kazakhstan in 2021: retrospective population-based cohort study.Front Public Health2023https://conductscience.org/library/papers/37351091PubMed
1133643630COVID-19 in Kyrgyzstan: Navigating a way out.J Glob Health2021https://conductscience.org/library/papers/33643630PubMed
1238877440The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis.BMC Public Health2024https://conductscience.org/library/papers/38877440PubMed
1341122532Outpatient pediatric care during the COVID-19 pandemic, Almaty, Kazakhstan 2021-2022.Front Public Health2025https://conductscience.org/library/papers/41122532PubMed
1433513204The differential impact of pediatric COVID-19 between high-income countries and low- and middle-income countries: A systematic review of fatality and ICU admission in children worldwide.PLoS One2021https://conductscience.org/library/papers/33513204PubMed
1541094663Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology.Biol Sex Differ2025https://conductscience.org/library/papers/41094663PubMed
1638903591The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia.Front Public Health2024https://conductscience.org/library/papers/38903591PubMed
1739939733The burden of COVID-19 in primary care of Almaty, Kazakhstan, 2021-2022.Sci Rep2025https://conductscience.org/library/papers/39939733PubMed
1833296578Anticipating the Need for Healthcare Resources Following the Escalation of the COVID-19 Outbreak in the Republic of Kazakhstan.J Prev Med Public Health2020https://conductscience.org/library/papers/33296578PubMed
1935758009Early Lift of Restrictions in Mongolia During the COVID-19 Pandemic: Child Rights, Public Trust, and Social Inequality.Asia Pac J Public Health2022https://conductscience.org/library/papers/35758009PubMed
2034016043SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality.BMC Infect Dis2021https://conductscience.org/library/papers/34016043PubMed

See all 39 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42332001

GET https://conductscience.org/api/papers/v1/42332001/references?page=2